FRAG-STER (HUMAN GROWTH HORMONE FRAGMENT 177-191)

 ACTIVE HALF LIFE
 CLASSIFICATION PEPTIDE HORMONE
 DOSAGE 250-300mcg
 ACNE NO
 WATER RETENTION NO
 HEPATOXITY NO
 AROMATIZATION NO
 MANUFACTURER STERIS LABS

 

Description

According to scientific study that has been based on animal test subjects, Fragment 177-191 has been shown to possess the ability to stimulate the process of lipolysis and slow down the process of lipogenesis. What’s more, it has been determined that the peptide’s functionality is very selective in the sense that it will only work with obese cells in order to release fat. This has led to the notion that the peptide could play a key role in enabling an animal test subject to experience a more efficient means of weight loss. It has also shown that the peptide has the capacity to boost blood glucose levels over a short period of time, and can enable a longer lasting boost of insulin levels to occur, provided that the peptide’s sequential chain is arranged correctly.

Additional scientific study based on animal test subjects has determined that there may be a link between Fragment 177-191, mental preservation and mental degradation – specifically as it relates to Alzheimer’s and Parkinson’s disease. It is thought that the presence of the peptide could conceivably play a part in prohibiting the kind of basal lesions that have been determined to contribute to the onset of Parkinson’s disease. It has also been thought that the peptide could offset the levels of toxicity that stem from the kind of protein malfunctions present at the onset of Alzheimer’s.